Assertion: chronic lymphocytic leukemia | /r/HasProperty | cll
Facets:
Source sentences:
text: What is chronic lymphocytic leukemia ( CLL )?
text: Chronic lymphocytic leukemia (also called CLL) is a blood and bone marrow disease that usually gets worse slowly.
text: Chronic lymphocytic leukemia, also known as CLL, is a type of cancer that develops very slowly in the bone marrow.
text: If You Have Chronic Lymphocytic Leukemia (CLL)
text: What is chronic lymphocytic leukemia (CLL)?
text: What is chronic lymphocytic leukemia (CLL)?
text: Symptoms of Chronic Lymphocytic Leukemia (CLL)
text: About 21,040 new cases of chronic lymphocytic leukemia (CLL)
text: Chronic lymphocytic leukemia (CLL)
text: In chronic lymphocytic leukemia (CLL), there are too many lymphocytes, a type of white blood cell.
text: Chronic lymphocytic leukemia (CLL)
text: As a result, chronic lymphocytic leukemia (CLL) is often widespread when it is found.
text: Leukemia is often lumped together, but there are actually a few different forms of the cancer—the most common in adults being one called chronic lymphocytic leukemia (CLL).
text: What is Chronic Lymphocytic Leukemia (CLL)?
text: When given this way, these drugs enter the bloodstream and reach all parts of the body, so chemo is useful for cancers that tend to spread throughout the body, like chronic lymphocytic leukemia (CLL).
text: What is Chronic Lymphocytic Leukemia (CLL)?
text: Chronic Lymphocytic Leukemia (CLL)
text: What is Chronic Lymphocytic Leukemia (CLL)?
text: Learn more about Chronic Lymphocytic Leukemia (CLL) Associated drugs
text: In chronic lymphocytic leukemia (CLL), the developing lymphocytes are overproduced and do not mature correctly.
text: This section focuses on different types of chronic T-cell lymphocytic leukemia, a subtype of chronic lymphocytic leukemia (CLL).
text: There are very few known risk factors for chronic lymphocytic leukemia (CLL).
text: Chronic lymphocytic leukemia (CLL) stages
text: Leukemia is often lumped together, but there are actually a few different forms of the cancer—the most common in adults being one called chronic lymphocytic leukemia (CLL).
text: If you have chronic lymphocytic leukemia (CLL), your healthcare team will create a treatment plan just for you.
text: Chronic lymphocytic leukemia (CLL)
text: Cancer that forms in blood and bone marrow is called chronic lymphocytic leukemia (CLL).
text: But for chronic lymphocytic leukemia (CLL) , no screening tests are routinely recommended at this time.
text: This report provides comprehensive information on the therapeutic development for Chronic Lymphocytic Leukemia (CLL), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
text: Chronic Lymphocytic Leukemia (CLL)
text: What is Chronic Lymphocytic Leukemia (CLL)?
text: Get The Best Care for Your Chronic Lymphocytic Leukemia (CLL)
text: Chronic lymphocytic leukemia (CLL)
text: Chemo given along with a monoclonal antibody is a standard treatment for chronic lymphocytic leukemia (CLL).
text: Chronic Lymphocytic Leukemia (CLL) Defined from Patient Empowerment Network on Vimeo.
text: Chronic lymphocytic leukemia (CLL): This leukemia is extremely rare in children.
text: Chronic Lymphocytic Leukemia (CLL)
text: Targeted Antibodies Alemtuzumab (Campath®): a monoclonal antibody that targets the CD52 pathway; approved for subsets of patients with chronic lymphocytic leukemia (CLL)
text: Chronic Lymphocytic Leukemia (CLL) –
text: What is chronic lymphocytic leukemia (CLL)?
text: At MSK, we have a team of experts in chronic lymphocytic leukemia (CLL).
text: Chronic lymphocytic leukemia (CLL)
text: A blood test is usually enough to find signs of chronic lymphocytic leukemia (CLL) .
text: Chronic Lymphocytic Leukemia (CLL) in combination with FC chemotherapy as an initial treatment or as a treatment after disease has recurred
text: Chronic lymphocytic leukemia (CLL): CLL affects lymphoid cells and usually grows slowly.
text: Chronic Lymphocytic Leukemia (CLL)
text: Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults.
text: Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made.
text: Chronic lymphocytic leukemia (CLL) is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell).
text: The exact cause of most cases of chronic lymphocytic leukemia (CLL) is not known.
text: In this article, we talk about survival rates for chronic lymphocytic leukemia (CLL) and the factors that can influence a person’s life expectancy.
text: Chronic lymphocytic leukemia (CLL), on the other hand, does not usually form tumors.
text: Chronic lymphocytic leukemia (CLL) can rarely be cured.
text: The first, and most common, is chronic lymphocytic leukemia (CLL).
text: Chronic lymphocytic leukemia Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow.
text: Chronic lymphocytic leukemia (CLL) is a cancer that affects a type of white blood cell called a lymphocyte.
text: Many people with chronic lymphocytic leukemia (CLL) do not have any symptoms when it is diagnosed.
text: Chronic lymphocytic leukemia (CLL) is a type of blood cancer that begins in the bone marrow.
text: However, one of the most common symptoms of chronic lymphocytic leukemia (CLL) is swollen lymph nodes in the neck, chest or groin.
text: Chronic lymphocytic leukemia (CLL) is a cancer that starts in blood stem cells.
text: According to Dr. Jacqueline Barrientos, Chronic Lymphocytic Leukemia (CLL) is the most common chronic leukemia in America and Europe with 15,000 new cases in the US every year.
text: Chronic lymphocytic leukemia (CLL) is a slow-growing blood cancer.
text: For most people who have chronic lymphocytic leukemia (CLL), there are no obvious reasons why they developed the disease.
text: Research on chronic lymphocytic leukemia (CLL) is taking place in many university hospitals, medical centers, and other institutions around the world.
text: Chronic lymphocytic leukemia (CLL) starts in bone marrow, the soft inner part of your bones.
text: Ludwig had chronic lymphocytic leukemia (CLL), another cancer that affects B-cells.
text: Chronic lymphocytic leukemia (CLL) is the most common chronic leukemia in adults.
text: For most people who have chronic lymphocytic leukemia (CLL), there are no obvious reasons why they developed the disease.
text: Chronic lymphocytic leukemia (CLL) is a type of cancer that involves certain white blood cells (lymphocytes) that develop in the bone marrow and lymph nodes.
text: Chronic lymphocytic leukemia (CLL) is a cancer of the lymphocytes.
text: Chronic lymphocytic leukemia (CLL) is a typically slow-growing cancer that begins in lymphocytes in the bone marrow and extends into the blood.
text: An initial diagnosis of chronic lymphocytic leukemia (CLL) may be surprising because it often doesn’t present with physical symptoms.
text: Treatment options for chronic lymphocytic leukemia (CLL) can vary greatly.
text: Chronic lymphocytic leukemia (CLL) is a typically slow-growing cancer that begins in the bone marrow and extends into the blood.
text: While there’s no specific dietary guidelines for people with chronic lymphocytic leukemia (CLL), certain diet patterns may help boost your energy and support recovery.
text: Chronic lymphocytic leukemia (CLL) is a type of leukemia where the bone marrow produces abnormal lymphocytes which are not able to function properly.
text: People with chronic lymphocytic leukemia (CLL) may have questions about their prognosis and survival.
text: Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made.
text: Chronic Lymphocytic Leukemia (CLL) is a cancer of blood cells called lymphocytes.
text: Chronic lymphocytic leukemia (CLL) usually grows slowly.
text: These subtypes are called chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
text: Chronic lymphocytic leukemia (CLL) is one type of cancer of the bone marrow and blood.
text: To learn more about chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), download the Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma Fact Sheet.
text: Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the Western world, accounting for up to 35% of all leukemias and 1.3% of all
text: Chronic lymphocytic leukemia (CLL) is a cancer that occurs when the bone marrow makes too many lymphocytes, a type of white blood cell.
text: Chronic lymphocytic leukemia (CLL) is a form of cancer which starts in the bone marrow.
text: Treatment of chronic lymphocytic leukemia (CLL) must be individualized on the basis of the clinical behavior of the disease.
text: Like other types of leukemia, chronic lymphocytic leukemia (CLL) begins in the stem cells of the bone marrow.
text: Chronic lymphocytic leukemia (CLL).
text: Chronic lymphocytic leukemia (CLL) is a blood cancer where there are too many of a specific type of white blood cell called a lymphocyte.
text: Chronic lymphocytic leukemia (CLL) is a cancer of the blood in which too many lymphocytes, a type of white blood cell, are produced by the bone marrow and by organs of the lymph system.
text: Chronic lymphocytic leukemia (CLL) is a disorder in which the lymphocytes lose their normal ability to die and end up accumulating over time.
text: UCSF delivers the most advanced treatment options for chronic lymphocytic leukemia (CLL) with care and compassion.
text: Chronic lymphocytic leukemia (CLL), the most frequent form of leukemia in Western countries, is characterized by the clonal proliferation and accumulation of neoplastic B lymphocytes in the blood, bone marrow, lymph nodes, and spleen.
text: There are four main types of leukemia—acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (
text: Chronic lymphocytic leukemia (CLL) is a cancer of the blood in which too many lymphocytes, a type of white blood cell, are produced by the bone marrow and by organs of the lymph system.
text: Chronic lymphocytic leukemia (CLL) is a type of cancer that affects your bone marrow and blood.
text: Chronic lymphocytic leukemia (CLL) is a slowly developing cancer that affects the white blood cells in the bone marrow.
text: They have a team of Health Advisors that want to help you manage your CLL diagnosis, and we were able to reserve 250 free spots for members with Chronic Lymphocytic Leukemia (CLL).
text: Chronic Lymphocytic Leukemia (CLL) is a slowly progressing blood and bone marrow disease.
text: The chronic lymphocytic leukemia (CLL) can affect the group of white blood cells in your blood.
text: Chronic Lymphocytic Leukemia (CLL) is a problem that can never alleviate completely.
text: Chronic lymphocytic leukemia (CLL) is a cancer of the immune system.
text: Just six months ago, I was diagnosed with chronic lymphocytic leukemia (CLL).
text: Chronic Lymphocytic Leukemia (CLL) is the most common adult hematologic malignancy in the United States.
text: To diagnose chronic lymphocytic leukemia (CLL), there needs to be ≥5000 monoclonal (genetically identical) B-lymphocytes (a type of white blood cell) in the blood for the duration of at least three months.
text: Staging of blood cancers like chronic lymphocytic leukemia (CLL) is different from that of other cancers because CLL does not form a solid tumour.
text: The prognosis of Chronic Lymphocytic Leukemia (CLL) is rather mixed.
text: Genetic markers can tell you and your doctor specific information about your chronic lymphocytic leukemia (CLL) and help1-3 Determine whether your CLL is low or high risk
text: Chronic lymphocytic leukemia (CLL) is one of the most common lymphoid malignancies, accounting for more than 10% of all lymphoid neoplasms, and is the most common adult leukemia in Western countries, with an age-adjusted annual incidence rate of about 4 cases per 100.000 men and women (1), (2).
text: Chronic lymphocytic leukemia (CLL) is a type of blood cancer that involves lymphocytes—white blood cells that help fight infections.
text: For patients with chronic lymphocytic leukemia (CLL) that has stopped responding to treatment, a new drug combination may be an effective option.
text: Doctors run tests to confirm a chronic lymphocytic leukemia (CLL) diagnosis and determine the cancer stage and other factors of your CLL.
text: Chronic lymphocytic leukemia (CLL) is a cancer that starts in blood stem cells.
text: Chronic lymphocytic leukemia (CLL) is the most common leukemia in the U.S.
text: Most people with chronic lymphocytic leukemia (CLL) get diagnosed before this cancer reaches its advanced stages.
text: Chronic lymphocytic leukemia (CLL) occurs most often in people over age 50 and worsens gradually over time.
text: The two chronic leukemias are chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML).
text: Chronic lymphocytic leukemia (CLL) is a monoclonal proliferation of small lymphocytes.
text: Although many people will show no symptoms of chronic lymphocytic leukemia (CLL), those that do typically develop large lymph nodes and experience unexplained fatigue and abnormal bruising.
text: Dr. Brian Hill defines chronic lymphocytic leukemia (CLL) and explains how it differs from small lymphocytic lymphoma (SLL).
text: Radiation therapy is seldom part of the main treatment for people with chronic lymphocytic leukemia (CLL), but it may be used in certain situations.
text: Chronic lymphocytic leukemia (CLL) does not occur in young children but may be found in teenagers.
text: The Food and Drug Administration (FDA) approved venetoclax (Venclexta®) on April 11 for patients with chronic lymphocytic leukemia (CLL) whose tumors have a specific genetic alteration.
text: How is chronic lymphocytic leukemia (CLL) diagnosed?
text: Chronic lymphocytic leukemia (CLL) is characterized by progressive accumulation of phenotypically mature malignant B lymphocytes.
text: Chronic lymphocytic leukemia (CLL) is characterized by a very heterogeneous clinical course.
text: About Chronic Lymphocytic Leukemia: Chronic lymphocytic leukemia (CLL) is cancer in your blood and bone marrow.
text: On the other hand, Chronic Lymphocytic Leukemia (CLL) is another variety of leukemia whose pathological basis is the abnormalities in the clonal expansion of B lymphocytes.
text: Chronic lymphocytic leukemia (CLL), also known as chronic lymphoid leukemia, is an oncological condition that is distinguished by the progressive accretion of non-functioning lymphocytes.
text: Dr. Tim Call describes Chronic Lymphocytic Leukemia (CLL), its diagnosis, and treatment options for patients with CLL.
text: Chronic lymphocytic leukemia (CLL) is a cancer that starts in blood stem cells.
text: SLL is one type of non-Hodgkin lymphoma, along with chronic lymphocytic leukemia (CLL).
text: Survival statistics for chronic lymphocytic leukemia (CLL) are very general estimates and must be interpreted very carefully.
text: When your doctor tells you it's time to treat your chronic lymphocytic leukemia (CLL)
text: Chronic lymphocytic leukemia (CLL) is a typically slow-growing cancer that begins in lymphocytes in the bone marrow and extends into the blood.
text: Hairy cell leukemia (HCL) is a rare subtype of chronic lymphocytic leukemia (CLL) that progresses slowly.
text: Chronic Lymphocytic Leukemia (CLL) is a type of cancer that starts from white blood cells (lymphocytes) in the bone marrow, from where it invades the blood.
text: Each year, nearly 7,000 people in the United States learn that they have Chronic Lymphocytic Leukemia (CLL).
text: Chronic lymphocytic leukemia (CLL) is an aggressive disease that is often discovered after routine or unrelated bloodwork is done.
text: Patients with chronic lymphocytic leukemia (CLL) who feel more stress also have more cancer cells in their blood and elevated levels of three other markers of more advanced disease.
text: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
text: Chronic Lymphocytic Leukemia (CLL) is a low-grade lymphoproliferative malignancy in which there is a proliferation of small mature lymphocytes (almost always B cells) in the blood, bone marrow, spleen, and lymph nodes.
text: Treatment has changed significantly for chronic lymphocytic leukemia (CLL) since around 2014.
text: a monoclonal antibody that targets the CD20 pathway; approved for subsets of patients with CD20-positive chronic lymphocytic leukemia (CLL), including as a first-line therapy Rituximab (Rituxan®): a monoclonal antibody that targets the CD20 pathway; approved for subsets of patients with chronic lymphocytic leukemia (CLL), including as a first-line therapy Adoptive Cell Therapy Tisagenlecleucel (Kymriah®): a CD19-targeting CAR T cell immunotherapy; approved for subsets of children and young adult patients with acute lymphoblastic leukemia
text: Surgery has a very limited role in treating chronic lymphocytic leukemia (CLL).
text: With the availability of a number of effective targeted agents for the treatment of chronic lymphocytic leukemia (CLL), the question arises whether chemotherapy still has a role in treating this malignancy.
text: Chronic lymphocytic leukemia (CLL) is a cancer that affects a type of white blood cell called “lymphocyte“, it belongs to one of the four major types of leukemia.
text: There is no cure for chronic lymphocytic leukemia (CLL), one of the most commonly diagnosed leukemias in the Western Hemisphere.
text: People with chronic lymphocytic leukemia (CLL) may notice enlarged lymph nodes in the neck, armpit, or groin, and have frequent infections.
text: Chronic lymphocytic leukemia (CLL) is rare in people under age 30.
text: Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are often considered different versions of the same disease because they are very similar.
text: Chronic lymphocytic leukemia (CLL) is a disease that commonly affects adults who are aged 55 years and above.
text: General considerations in the staging of chronic lymphocytic leukemia (CLL) and the revised Rai (United States) and Binet (Europe) staging systems for CLL are provided below.
text: On May 15, the Food and Drug Administration (FDA) approved venetoclax (Venclexta) in combination with obinutuzumab (Gazyva) for the initial treatment of adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
text: Chronic lymphocytic leukemia (CLL) is most often diagnosed during a routine blood test.
text: Treatment of chronic lymphocytic leukemia (CLL), one of four common types of leukemia, requires an individualized approach.
text: The U.S. Food and Drug Administration (FDA) approved duvelisib (COPIKTRA) for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after at least two prior therapies.
text: The U.S. Food and Drug Administration (FDA) approved venetoclax (VENCLEXTA) for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without 17p deletion, who have received at least one prior therapy.
text: The U.S. Food and Drug Administration (FDA) approved the use of ibrutinib (Imbruvica) for front-line use in the treatment of chronic lymphocytic leukemia (CLL), representing the first chemotherapy-free treatment option of its kind available to patients regardless of treatment history.
text: The U.S. Food and Drug Administration (FDA) has approved a new drug application for bendamustine hydrochloride (Bendeka) for treatment of patients with chronic lymphocytic leukemia (CLL) and treatment of patients with indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab containing regimen.
text: The U.S. Food and Drug Administration (FDA) expanded the approved use of ibrutinib (Imbruvica) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL.
text: The U.S. Food and Drug Administration (FDA) approved ofatumumab (Arzerra) in combination with chlorambucil, for the treatment of previously untreated patients with chronic lymphocytic leukemia (CLL), for whom fludarabine-based therapy is considered inappropriate.
text: The U.S. Food and Drug Administration (FDA) granted accelerated approval to ibrutinib (Imbruvica) for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
text: Chronic lymphocytic leukemia (CLL), one of the four types of leukemia, starts with a change to a single cell, an infection-fighter called a lymphocyte.
text: Supportive care for chronic lymphocytic leukemia (CLL) is aimed at helping with problems related to the cancer and its treatment.
text: I have chronic lymphocytic leukemia (CLL) and experience night sweats brought on by my disease.
text: Diagnosing chronic lymphocytic leukemia (CLL) requires a physical examination and examination of the blood.
text: NYU Langone doctors use the results of sophisticated blood and tissue tests to diagnose chronic lymphocytic leukemia (CLL), a cancer of the blood and bone marrow.
text: Most patients with chronic lymphocytic leukemia (CLL) are diagnosed with early-stage disease and managed with active surveillance.
text: Chronic lymphocytic leukemia (CLL) is characterized by the relentless accumulation of monoclonal B lymphocytes with a distinct immunophenotype (ie, CD5, CD19, CD20, CD23) in peripheral blood, bone marrow, and lymphoid organs.
text: Chronic lymphocytic leukemia (CLL) is a cancer that starts in blood stem cells.
text: Chemotherapy used in chronic lymphocytic leukemia (CLL) mostly works by damaging the DNA of dividing cells.
text: However, the most common form of B-cell leukemia, accounting for 37 percent of all cases, is chronic lymphocytic leukemia (CLL).
text: Chronic lymphocytic leukemia (CLL) is one of the four main kinds of leukemia that exist.
text: Doctors may use watchful waiting for patients with chronic lymphocytic leukemia (CLL) at first because treatment may not be needed.
text: Chronic lymphocytic leukemia (CLL) may be treated with medicines, such as chemotherapy, corticosteroids, and monoclonal antibodies.
text: Medicines used for treatments for chronic lymphocytic leukemia (CLL) are taken orally (by mouth) or given intravenously for limited periods of time.
text: In rare cases of chronic lymphocytic leukemia (CLL), the spleen needs to be removed.
text: Symptoms of Chronic Lymphocytic Leukemia (CLL), Also Known as Small Lymphocytic Lymphoma (SLL)
text: Chronic lymphocytic leukemia (CLL) is the most common of the four primary forms of leukemia: the acute and chronic forms of lymphocytic leukemia and acute and chronic forms of myeloid leukemia.
text: Chronic Lymphocytic Leukemia (CLL) is one of the most common types of adult leukemia, usually affecting individuals who are more than 50 years of age.
text: Chronic Lymphocytic Leukemia (CLL) is one of the four main types of cancer that affects the blood and the bone marrow.
text: With an age‐adjusted incidence of 4.1/100 000 inhabitants in the United States, chronic lymphocytic leukemia (CLL) is the most common type of leukemia in western countries.
text: The four major types of leukemia are chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), and acute myeloid leukemia (AML).
text: It can come as quite a shock when you are first diagnosed with chronic lymphocytic leukemia (CLL).
text: Chronic lymphocytic leukemia (CLL) shares some similar features and symptoms with other closely related types of leukemia.
text: The effects of chronic lymphocytic leukemia (CLL) on a patient
text: Most patients with chronic lymphocytic leukemia (CLL) now have several options for first-line therapy, thanks to new clinical trial results and novel targeted agents.
text: Chronic lymphocytic leukemia (also called CLL) is a blood and bone marrow disease that usually gets worse slowly.